NCT06224959 Migraine and Neuropathic Pain in Osteoarthritis
| NCT ID | NCT06224959 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Clermont-Ferrand |
| Condition | Osteoarthritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-03-27 |
| Primary Completion | 2028-03-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-03-27 with a primary completion date of 2028-03-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to estimate the frequency of neuropathic pain and migraines in a group of patients with osteoarthritis of the knees, hips, hands, spine or other joints. In addition to their usual care for osteoarthritis, participants will complete questionnaires to define migraine and neuropathic pain.
Eligibility Criteria
Inclusion Criteria: * patients over 18 years old * patients with articular or/and spinal osteoarthritis * affiliation to a social security system. * able to read and understand french Exclusion Criteria: * patients who refuse to participate in the study * patients unable to complete self-questionnaires * minors or adults under the protection of the law or under the protection of justice
Contact & Investigator
Sylvain MATHIEU
PRINCIPAL INVESTIGATOR
University Hospital, Clermont-Ferrand
Frequently Asked Questions
Who can join the NCT06224959 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06224959 currently recruiting?
Yes, NCT06224959 is actively recruiting participants. Contact the research team at promo_interne_drci@chu-clermontferrand.fr for enrollment information.
Where is the NCT06224959 trial being conducted?
This trial is being conducted at Clermont-Ferrand, France.
Who is sponsoring the NCT06224959 clinical trial?
NCT06224959 is sponsored by University Hospital, Clermont-Ferrand. The principal investigator is Sylvain MATHIEU at University Hospital, Clermont-Ferrand. The trial plans to enroll 1,000 participants.